Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Endokrynologia Polska
MENU
Shortcuts Submit an article Author Guidelines Polish Society of Endocrinology Reviewers 2023 Redeem voucher

open access

Vol 74, No 2 (2023)
Review paper
Submitted: 2022-03-31
Accepted: 2022-07-06
Published online: 2023-02-21
View PDF Download PDF file View HTML
Get Citation

Optical coherence tomography angiography for assessment of changes of the retina and choroid in different stages of diabetic retinopathy and their relationship with diabetic nephropathy

Yingying Chen123, Zhihao Qi, Xinguo Hou123, Li Chen123
DOI: 10.5603/EP.a2022.0085
·
Pubmed: 36916544
·
Endokrynol Pol 2023;74(2):135-139.
Affiliations
  1. Department of Endocrinology, Qilu Hospital, Shandong University, Jinan, Shandong, China
  2. Institute of Endocrine and Metabolic Diseases of Shandong University, Jinan, Shandong, China
  3. Key Laboratory of endocrine and Metabolic Diseases, Shandong province Medicine and Health, Jinan, Shandong, China

open access

Vol 74, No 2 (2023)
Review Article
Submitted: 2022-03-31
Accepted: 2022-07-06
Published online: 2023-02-21

Abstract

Given the prevalence of diabetes worldwide, diabetic retinopathy (DR) has become the most prominent cause of blindness. However, DR can be diagnosed only when it is severe enough to be clinically detectable. Several studies have evaluated the correlation between DR and diabetic nephropathy (DN) by utilizing optical coherence tomography angiography (OCTA). Compared with other diagnostic techniques, such as fluorescein angiography and fundus photography, OCTA has the ability to directly reflect the condition of the retinal and choroidal microcirculation at an early stage. This review focuses on the following aspects: the advantages of OCTA, the pathophysiology of DR, changes in OCTA images in patients with DR, and the relationships between OCTA parameters and renal function.

Abstract

Given the prevalence of diabetes worldwide, diabetic retinopathy (DR) has become the most prominent cause of blindness. However, DR can be diagnosed only when it is severe enough to be clinically detectable. Several studies have evaluated the correlation between DR and diabetic nephropathy (DN) by utilizing optical coherence tomography angiography (OCTA). Compared with other diagnostic techniques, such as fluorescein angiography and fundus photography, OCTA has the ability to directly reflect the condition of the retinal and choroidal microcirculation at an early stage. This review focuses on the following aspects: the advantages of OCTA, the pathophysiology of DR, changes in OCTA images in patients with DR, and the relationships between OCTA parameters and renal function.

Full Text:

View PDF Download PDF file View HTML
Get Citation

Keywords

optical coherence tomography angiography; diabetic retinopathy; diabetic nephropathy; pathogenesis; correlation

About this article
Title

Optical coherence tomography angiography for assessment of changes of the retina and choroid in different stages of diabetic retinopathy and their relationship with diabetic nephropathy

Journal

Endokrynologia Polska

Issue

Vol 74, No 2 (2023)

Article type

Review paper

Pages

135-139

Published online

2023-02-21

Page views

2761

Article views/downloads

666

DOI

10.5603/EP.a2022.0085

Pubmed

36916544

Bibliographic record

Endokrynol Pol 2023;74(2):135-139.

Keywords

optical coherence tomography angiography
diabetic retinopathy
diabetic nephropathy
pathogenesis
correlation

Authors

Yingying Chen
Zhihao Qi
Xinguo Hou
Li Chen

References (54)
  1. Aronov M, Allon R, Stave D, et al. Retinal Vascular Signs as Screening and Prognostic Factors for Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Current Evidence. J Pers Med. 2021; 11(7).
    CrossRefPubMed
  2. Petropoulos IN, Alam U, Fadavi H, et al. Corneal nerve loss detected with corneal confocal microscopy is symmetrical and related to the severity of diabetic polyneuropathy. Diabetes Care. 2013; 36(11): 3646–3651.
    CrossRefPubMed
  3. Garcia JM, Lima TT, Louzada RN, et al. Diabetic Macular Ischemia Diagnosis: Comparison between Optical Coherence Tomography Angiography and Fluorescein Angiography. J Ophthalmol. 2016; 2016: 3989310.
    CrossRefPubMed
  4. Campbell JP, Zhang M, Hwang TS, et al. Detailed Vascular Anatomy of the Human Retina by Projection-Resolved Optical Coherence Tomography Angiography. Sci Rep. 2017; 7: 42201.
    CrossRefPubMed
  5. Mastropasqua R, Toto L, Mastropasqua A, et al. Foveal avascular zone area and parafoveal vessel density measurements in different stages of diabetic retinopathy by optical coherence tomography angiography. Int J Ophthalmol. 2017; 10(10): 1545–1551.
    CrossRefPubMed
  6. Akil H, Karst S, Heisler M, et al. Application of optical coherence tomography angiography in diabetic retinopathy: a comprehensive review. Can J Ophthalmol. 2019; 54(5): 519–528.
    CrossRefPubMed
  7. Schwartz DM, Fingler J, Kim DYu, et al. Phase-variance optical coherence tomography: a technique for noninvasive angiography. Ophthalmology. 2014; 121(1): 180–187.
    CrossRefPubMed
  8. Salz DA, de Carlo TE, Adhi M, et al. Select Features of Diabetic Retinopathy on Swept-Source Optical Coherence Tomographic Angiography Compared With Fluorescein Angiography and Normal Eyes. JAMA Ophthalmol. 2016; 134(6): 644–650.
    CrossRefPubMed
  9. Couturier A, Mané V, Bonnin S, et al. CAPILLARY PLEXUS ANOMALIES IN DIABETIC RETINOPATHY ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Retina. 2015; 35(11): 2384–2391.
    CrossRefPubMed
  10. Lee CS, Lee AY, Sim DA, et al. Reevaluating the definition of intraretinal microvascular abnormalities and neovascularization elsewhere in diabetic retinopathy using optical coherence tomography and fluorescein angiography. Am J Ophthalmol. 2015; 159(1): 101–110.e1.
    CrossRefPubMed
  11. Muqit MMK, Stanga PE. Fourier-domain optical coherence tomography evaluation of retinal and optic nerve head neovascularisation in proliferative diabetic retinopathy. Br J Ophthalmol. 2014; 98(1): 65–72.
    CrossRefPubMed
  12. Cho H, Alwassia AA, Regiatieri CV, et al. Retinal neovascularization secondary to proliferative diabetic retinopathy characterized by spectral domain optical coherence tomography. Retina. 2013; 33(3): 542–547.
    CrossRefPubMed
  13. Vujosevic S, Midena E. Retinal layers changes in human preclinical and early clinical diabetic retinopathy support early retinal neuronal and Müller cells alterations. J Diabetes Res. 2013; 2013: 905058.
    CrossRefPubMed
  14. El-Fayoumi D, Badr Eldine NM, Esmael AF, et al. Retinal Nerve Fiber Layer and Ganglion Cell Complex Thicknesses Are Reduced in Children With Type 1 Diabetes With No Evidence of Vascular Retinopathy. Invest Ophthalmol Vis Sci. 2016; 57(13): 5355–5360.
    CrossRefPubMed
  15. van Dijk HW, Verbraak FD, Kok PHB, et al. Early neurodegeneration in the retina of type 2 diabetic patients. Invest Ophthalmol Vis Sci. 2012; 53(6): 2715–2719.
    CrossRefPubMed
  16. Zafar S, Sachdeva M, Frankfort BJ, et al. Retinal Neurodegeneration as an Early Manifestation of Diabetic Eye Disease and Potential Neuroprotective Therapies. Curr Diab Rep. 2019; 19(4): 17.
    CrossRefPubMed
  17. Zeng Y, Cao D, Yu H, et al. Early retinal neurovascular impairment in patients with diabetes without clinically detectable retinopathy. Br J Ophthalmol. 2019; 103(12): 1747–1752.
    CrossRefPubMed
  18. Li L, Almansoob S, Zhang Pu, et al. Quantitative analysis of retinal and choroid capillary ischaemia using optical coherence tomography angiography in type 2 diabetes. Acta Ophthalmol. 2019; 97(3): 240–246.
    CrossRefPubMed
  19. Klaassen I, Van Noorden CJF, Schlingemann RO. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions. Prog Retin Eye Res. 2013; 34: 19–48.
    CrossRefPubMed
  20. Solomon SD, Chew E, Duh EJ, et al. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017; 40(3): 412–418.
    CrossRefPubMed
  21. Simó R, Stitt AW, Gardner TW. Neurodegeneration in diabetic retinopathy: does it really matter? Diabetologia. 2018; 61(9): 1902–1912.
    CrossRefPubMed
  22. Song SuJ, Wong TY. Current concepts in diabetic retinopathy. Diabetes Metab J. 2014; 38(6): 416–425.
    CrossRefPubMed
  23. Salvi L, Plateroti P, Balducci S, et al. Abnormalities of retinal ganglion cell complex at optical coherence tomography in patients with type 2 diabetes: a sign of diabetic polyneuropathy, not retinopathy. J Diabetes Complications. 2016; 30(3): 469–476.
    CrossRefPubMed
  24. Yang JY, Wang Q, Yan YNi, et al. Microvascular retinal changes in pre-clinical diabetic retinopathy as detected by optical coherence tomographic angiography. Graefes Arch Clin Exp Ophthalmol. 2020; 258(3): 513–520.
    CrossRefPubMed
  25. Dimitrova G, Chihara E, Takahashi H, et al. Quantitative Retinal Optical Coherence Tomography Angiography in Patients With Diabetes Without Diabetic Retinopathy. Invest Ophthalmol Vis Sci. 2017; 58(1): 190–196.
    CrossRefPubMed
  26. Inanc M, Tekin K, Kiziltoprak H, et al. Changes in Retinal Microcirculation Precede the Clinical Onset of Diabetic Retinopathy in Children With Type 1 Diabetes Mellitus. Am J Ophthalmol. 2019; 207: 37–44.
    CrossRefPubMed
  27. Karst SG, Heisler M, Lo J, et al. Evaluating Signs of Microangiopathy Secondary to Diabetes in Different Areas of the Retina with Swept Source OCTA. Invest Ophthalmol Vis Sci. 2020; 61(5): 8.
    CrossRefPubMed
  28. Di G, Weihong Yu, Xiao Z, et al. A morphological study of the foveal avascular zone in patients with diabetes mellitus using optical coherence tomography angiography. Graefes Arch Clin Exp Ophthalmol. 2016; 254(5): 873–879.
    CrossRefPubMed
  29. Um T, Seo EJ, Kim YJ, et al. Optical coherence tomography angiography findings of type 1 diabetic patients with diabetic retinopathy, in comparison with type 2 patients. Graefes Arch Clin Exp Ophthalmol. 2020; 258(2): 281–288.
    CrossRefPubMed
  30. Carnevali A, Sacconi R, Corbelli E, et al. Optical coherence tomography angiography analysis of retinal vascular plexuses and choriocapillaris in patients with type 1 diabetes without diabetic retinopathy. Acta Diabetol. 2017; 54(7): 695–702.
    CrossRefPubMed
  31. Niestrata-Ortiz M, Fichna P, Stankiewicz W, et al. Enlargement of the foveal avascular zone detected by optical coherence tomography angiography in diabetic children without diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2019; 257(4): 689–697.
    CrossRefPubMed
  32. van Dijk HW, Verbraak FD, Kok PHB, et al. Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes. Invest Ophthalmol Vis Sci. 2010; 51(7): 3660–3665.
    CrossRefPubMed
  33. van Dijk HW, Kok PHB, Garvin M, et al. Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy. Invest Ophthalmol Vis Sci. 2009; 50(7): 3404–3409.
    CrossRefPubMed
  34. Scarinci F, Nesper PL, Fawzi AA. Deep Retinal Capillary Nonperfusion Is Associated With Photoreceptor Disruption in Diabetic Macular Ischemia. Am J Ophthalmol. 2016; 168: 129–138.
    CrossRefPubMed
  35. Hidayat A, Fine B. Diabetic Choroidopathy. Ophthalmology. 1985; 92(4): 512–522.
    CrossRef
  36. Xu J, Xu L, Du KF, et al. Subfoveal choroidal thickness in diabetes and diabetic retinopathy. Ophthalmology. 2013; 120(10): 2023–2028.
    CrossRefPubMed
  37. Kim JT, Lee DH, Joe SG, et al. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients. Invest Ophthalmol Vis Sci. 2013; 54(5): 3378–3384.
    CrossRefPubMed
  38. Esmaeelpour M, Považay B, Hermann B, et al. Mapping choroidal and retinal thickness variation in type 2 diabetes using three-dimensional 1060-nm optical coherence tomography. Invest Ophthalmol Vis Sci. 2011; 52(8): 5311–5316.
    CrossRefPubMed
  39. Regatieri CV, Branchini L, Carmody J, et al. Choroidal thickness in patients with diabetic retinopathy analyzed by spectral-domain optical coherence tomography. Retina. 2012; 32(3): 563–568.
    CrossRefPubMed
  40. Yang SJ, Han YH, Song GIl, et al. Changes of choroidal thickness, intraocular pressure and other optical coherence tomographic parameters after haemodialysis. Clin Exp Optom. 2013; 96(5): 494–499.
    CrossRefPubMed
  41. Oliverio GW, Ceravolo I, Bhatti A, et al. Foveal avascular zone analysis by optical coherence tomography angiography in patients with type 1 and 2 diabetes and without clinical signs of diabetic retinopathy. Int Ophthalmol. 2021; 41(2): 649–658.
    CrossRefPubMed
  42. Manaviat MR, Afkhami M, Shoja MR. Retinopathy and microalbuminuria in type II diabetic patients. BMC Ophthalmol. 2004; 4: 9.
    CrossRefPubMed
  43. Chen H, Zheng Z, Huang Y, et al. A microalbuminuria threshold to predict the risk for the development of diabetic retinopathy in type 2 diabetes mellitus patients. PLoS One. 2012; 7(5): e36718.
    CrossRefPubMed
  44. Girach A, Manner D, Porta M. Diabetic microvascular complications: can patients at risk be identified? A review. Int J Clin Pract. 2006; 60(11): 1471–1483.
    CrossRefPubMed
  45. Billault B, Passa P. Factors associated with diabetic microangiopathy: A study of 157 type I (insulin-dependent) diabetic patients. J Diabet Complications. 1991; 5(4): 238–243.
    CrossRefPubMed
  46. Ebeling P, Koivisto VA. Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland. Acta Diabetol. 1997; 34(1): 33–38.
    CrossRefPubMed
  47. Cankurtaran V, Inanc M, Tekin K, et al. Retinal Microcirculation in Predicting Diabetic Nephropathy in Type 2 Diabetic Patients without Retinopathy. Ophthalmologica. 2020; 243(4): 271–279.
    CrossRefPubMed
  48. Yeung L, Wu IW, Sun CC, et al. Early retinal microvascular abnormalities in patients with chronic kidney disease. Microcirculation. 2019; 26(7): e12555.
    CrossRefPubMed
  49. Ahmadzadeh Amiri A, Sheikh Rezaee MR, Ahmadzadeh Amiri A, et al. Macular Optical Coherence Tomography Angiography in Nephropathic Patients with Diabetic Retinopathy in Iran: A Prospective Case-Control Study. Ophthalmol Ther. 2020; 9(1): 139–148.
    CrossRefPubMed
  50. Tom ES, Saraf SS, Wang F, et al. Retinal Capillary Nonperfusion on OCT-Angiography and Its Relationship to Kidney Function in Patients with Diabetes. J Ophthalmol. 2020; 2020: 2473949.
    CrossRefPubMed
  51. Zhang Yu, Weng H, Li Q, et al. Changes in retina and choroid after haemodialysis assessed using optical coherence tomography angiography. Clin Exp Optom. 2018; 101(5): 674–679.
    CrossRefPubMed
  52. Shin YUn, Lee DE, Kang MHo, et al. Optical coherence tomography angiography analysis of changes in the retina and the choroid after haemodialysis. Sci Rep. 2018; 8(1): 17184.
    CrossRefPubMed
  53. Ulaş F, Doğan Ü, Keleş A, et al. Evaluation of choroidal and retinal thickness measurements using optical coherence tomography in non-diabetic haemodialysis patients. Int Ophthalmol. 2013; 33(5): 533–539.
    CrossRefPubMed
  54. Jung JiW, Chin HS, Lee DH, et al. Changes in subfoveal choroidal thickness and choroidal extravascular density by spectral domain optical coherence tomography after haemodialysis: a pilot study. Br J Ophthalmol. 2014; 98(2): 207–212.
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl